Max Healthcare Approves Q3 FY26 Results and Expands Dwarka Hospital Capacity
Max Healthcare Institute Limited approved Q3 FY26 results on February 5, 2026. The company also approved an expansion of approximately 260 beds at its Dwarka hospital, expected within 24 months. The company will provide a ₹25 crore security deposit. Standalone revenue for nine months was ₹2,14,155 lakh, with PAT ₹51,348 lakh. Consolidated revenue was ₹6,23,056 lakh, with PAT ₹1,10,019 lakh.
The approval of financial results is routine. However, the capacity expansion at a major hospital location and the associated investment details have a moderate impact on the company's growth prospects.
The company approved its quarterly financial results and approved a capacity expansion, indicating positive business development and growth.
Max Healthcare Institute Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board of Directors, following the recommendation of the Audit Committee, approved these results during their meeting held on February 5, 2026. The meeting commenced at 11:05 am IST and concluded at 1:32 pm IST.
Additionally, the Board approved an amendment to the existing Services Agreement to extend the arrangement for approximately 260 additional beds being constructed by MHPL at the same site as the existing 300-bedded Max Super Speciality Hospital, Dwarka. This expansion is expected to be completed by MHPL within the next 24 months, strengthening Max Healthcare's presence in the Delhi NCR region. The company will provide an interest-free refundable security deposit of approximately ₹25 crore for this expansion, funded through internal accruals.
The company also reported its financial performance for the nine months ended December 31, 2025. In standalone results, revenue from operations was ₹2,14,155 lakh and profit after tax was ₹51,348 lakh. For consolidated results, revenue from operations stood at ₹6,23,056 lakh with a profit after tax of ₹1,10,019 lakh. The financial results were accompanied by unmodified limited review reports from the statutory auditors, M/s. S.R. Batliboi & Co. LLP.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.